| Application no. and date | 22715162.8 (espacenet) (Federated) (European Patent Register), 20220304 | | Patent/reg. no. and date | DK/EP 4125911, 20240424 | | Publication date | 20230208 | | Priority no. and date | US 202163157586 P, 20210305 | | EP pub. no. and date |
EP 4125911 20230208 | | Effective date | | | Applicant/owner | NewAmsterdam Pharma B.V., (dutch Chamber of Commerce No. 55971946)
Gooimeer 2-35
1411 DC Naarden, NL | | Applicant ref. no. | V478272DK00 | | Inventor | DITMARSCH, Marc,
1411 DC Naarden, NL,
KASTELEIN, Johannes Jacob Pieter,
1411 DC Naarden, NL,
DAVIDSON, Michael Harvey,
1411 DC Naarden, NL | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/506 (2006.01) , A61P 25/28 (2006.01) | | Title | Obicetrapib til behandling af demens | | Int. application no. | IB2022000098 | | Int. publication no. | WO2022185120 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
